You are here: Industry Insights > AstraZeneca

News List

EMA clears use of COVID-19 Vaccine AstraZeneca europeanpharmaceuticalreview
March 22, 2021
The EMA’s drug safety committee concluded that the vaccine is not associated with an increased risk of thromboembolic events and that its benefits still outweigh its risks.
AstraZeneca to supply 500,000 additional doses of COVID-19 antibody cocktail to US expresspharma
March 22, 2021
The drugmaker said the $205 million US extension for 500,000 antibody doses builds on a contract agreed with government agencies in October for initial supplies of 200,000 doses of the antibody cocktail, AZD7442.
EMA review concludes AstraZeneca Covid-19 vaccine is “safe and effective” pharmaceutical-technology
March 19, 2021
The European Medicines Agency (EMA) has concluded that the AstraZeneca/Oxford University Covid-19 vaccine is “safe and effective” after an investigation into a potential link between the vaccine and blood clots in a small number of patients.
EU warns about tougher export control of COVID vaccines as internal feuds intensify expresspharma
March 19, 2021
The European Commission threatened to ban COVID-19 vaccine exports to countries like Britain that have higher vaccination rates but do not export shots to the EU, as rifts over the scarcity of the shots deepened and the 27-nation bloc struggled to ...
SII gets purchase order from government for 10 crore doses of Covishield expresspharma
March 19, 2021
Serum Institute of India (SII) has received a new purchase order from the Government of India for the supply of 10-crore doses of the Oxford-AstraZeneca COVID-19 vaccine — Covishield — each dose costing Rs 157.5, including GST, according to official ...
NICE backs AstraZeneca’s Calquence for CLL pharmatimes
March 18, 2021
The UK National Institute for Health and Care Excellence (NICE) has recommended AstraZeneca’s Calquence for use on the NHS to treat a common form of leukaemia.
AstraZeneca Competes Viela Divestment americanpharmaceuticalreview
March 18, 2021
AstraZeneca has completed the divestment of its 26.7% ownership in Viela Bio, as part of the proposed acquisition of Viela by Horizon Therapeutics. This follows the agreement to divest the shareholding on February 1, 2021.
AstraZeneca to supply 500,000 doses of Covid-19 antibody to the US pharmaceutical-technology
March 18, 2021
AstraZeneca (AZ) has signed an agreement with the US Department of Health and Human Services (HHS) and the Department of Defense (DoD) for the supply of up to 500,000 additional doses of its Covid-19 antibody treatment for $205m.
EU countries suspend use of Covid-19 vaccine AstraZeneca pharmaceutical-technology
March 16, 2021
Several countries in Europe have suspended the University of Oxford / AstraZeneca (AZ) Covid-19 vaccine completely or partially after several suspected deaths were reported due to blood clotting following vaccination.
No evidence of greater blood clot risk from vaccine: AstraZeneca expresspharma
March 16, 2021
Its review covered more than 17 million people vaccinated in the UK and EU and comes after health authorities in some countries suspended the use of its vaccine over clotting issues.

Previous page 1 2 3 4 5 6 7 8 9 10 ... 80 81 Next page